In a recent study published in JAMA Oncology, investigators from the University of Bergen, in collaboration with the Women's Health Initiative study in the US, reported epigenetic gene silencing in normal tissue to be a predictive factor for triple-negative breast cancer (TNBC) as well as high-grade serous ovarian cancer (HGSOC).
More...